Problems in rare tumor study: a call for papers

Author:

Miller Robert C1

Affiliation:

1. Department of Radiation Oncology, Mayo Clinic, Rochester, MN, Minnesota, USA

Abstract

Rare tumor research presents many challenges. Large, randomized clinical trials are often impractical in this field and access to biospecimens may be problematic. These difficulties can best be addressed through multidisciplinary, national and international collaborative efforts among researchers, clinicians, governmental bodies, and patients. Numerous governmental and private organizations now exist to facilitate cooperation between researchers and institutions. Patient advocacy organizations now play an increasingly important role in partnering with traditional research groups to promote rare tumor research. Rare Tumors is now beginning an editorial series focusing on the problems of rare tumor research. We wish to invite all researchers and clinicians who are involved in rare tumor research and treatment to contribute their observations on the problems of working in this field, either as a letter to the editor, an editorial on a select issue, or as a review paper.

Publisher

SAGE Publications

Subject

Oncology,Histology

Reference8 articles.

1. National Institutes of Health: Office of Rare Disease ResearchRare Diseases and Related Terms2010cited 2010 January 29Available from: http://rarediseases.info.nih.gov/RareDiseaseList.aspx

2. Two decades of orphan product development

3. IDH1andIDH2Mutations in Gliomas

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3